Commodore Capital LP Arvinas, Inc. Transaction History
Commodore Capital LP
- $1.18 Billion
- Q3 2024
A detailed history of Commodore Capital LP transactions in Arvinas, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 1,200,000 shares of ARVN stock, worth $29 Million. This represents 2.51% of its overall portfolio holdings.
Number of Shares
1,200,000
Previous 1,884,361
36.32%
Holding current value
$29 Million
Previous $50.2 Million
41.08%
% of portfolio
2.51%
Previous 4.5%
Shares
4 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$169 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$163 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$151 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$93.2 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$67.3 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.29B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...